Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.